ATC Group: H02AB09 Hydrocortisone

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of H02AB09 in the ATC hierarchy

Level	Code	Title
`1`	H	Systemic hormonal preparations, excl. Sex hormones and insulins
`2`	H02	Corticosteroids for systemic use
`3`	H02A	CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
`4`	H02AB	Glucocorticoids
`5`	H02AB09	Hydrocortisone

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Code	Route	Amount	Notes
ORAL	Oral	30 mg
PAREN	Parenteral	30 mg

Active ingredients in H02AB09

Active Ingredient
Hydrocortisone
Hydrocortisone is the main glucocorticoid secreted by the adrenal cortex. Hydrocortisone is an anti-inflammatory steroid. Its anti-inflammatory action is due to reduction in the vascular component of the inflammatory response and reduction in the formation of inflammatory fluid and cellular exudates.

Related product monographs

Document	Type	Information Source
ALKINDI Granule in capsule	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
CORTEF Tablet	MPI, US: SPL/Old	FDA, National Drug Code (US)
HYDROCORTONE Tablet	MPI, EU: SmPC	Health Products Regulatory Authority (IE)
PLENADREN Modified-release tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
Solu-Cortef	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)